Join Now! /

Caeli Nova concludes its Series A round at CHF 10m with a second closing

Startacus RSS

by Startacus Admin


Further investment success for Caeli Nova to support breathing technology development in commercial aviation and beyond.

Caeli Nova breathing technology innovator, operating at the intersection of aviation and healthcare, has successfully completed a second closing of its Series A round of financing.

logo (This funding will support breathing technology development in commercial aviation and beyond, adding a further CHF 2m of investment to its CHF 8m first closing in December 2021. The second closing brings the Series A investment in Caeli Nova to a total of CHF 10m, setting the company on a strong path to installing Cordillera, onto its first aircraft during 2022 and further developing its technology to advance a long-overlooked aspect of aviation.

Cordillera, Caeli Nova’s launch product, is an onboard emergency oxygen system that enables aircraft to overcome limitations associated with existing systems, enabling aircraft to fly the most direct routes, and significantly reducing costs and carbon emissions for airlines. In addition, Cordillera removes operational constraints and limitations facing airlines, airframers and defence aerospace today, thereby allowing airlines to operate shorter flights, with associated reductions in fuel and carbon emissions.

cordillera-higher-altitude_83This latest investment round was syndicated by LG Capital, Switzerland-based venture builder and co-founder of Caeli Nova. As part of the second closing, Caeli Nova welcomed Swiss entrepreneur and investor Daniel S. Aegerter of Armada Investment. Within its venture portfolio, Armada has experience with multiple aviation innovators, such as Flytrex and Lilium.

Among Caeli Nova’s Series A investors, Armada joins this round’s lead investor Ornament Health, a Swiss digital health company, and Latécoère, a leading stock market listed Tier 1 aerospace manufacturer.

Tim Wakeford, CEO of Caeli Nova said: “The funding we’ve received in our Series A round has come from both the healthcare and aviation sectors, which truly speaks to the vision we share with our partners for Caeli Nova’s technology. This support brings us closer to installing our product initially in the aviation market and will also allow us to further explore possibilities in other sectors.”

Exciting times ahead for this hugely innovative startup!




Subscribe to our newsletter

If you would like to receive our startup themed newsletter, full of the latest startup opportunities, events, news, stories, tips and advice, then sign up here.
Startacus RSS
Business DealsSubmit Your Startup
Win TicketsNetwork and Collaborate
Our Latest Features

Published on: 22nd February 2022

If you would like to enable commenting via your Startacus account, please enable Disqus functionality in your Account Settings.

Create an Idea!View Other Ideas, Projects or Startups
Why not Sign Up?
Create Projects
Edit Projects
Self Interviews
Self Starter of the Year
Product Giveaways
Subscribe to our Newsletter
Check us out at our Google+ page!